Satellite Banner
Technology Networks Header
Thursday, October 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

High Throughput Biological Sample Concentrator
Tuesday, September 16, 2014
The miVac Quattro from Genevac is the perfect workhorse sample concentrator for biological laboratories tasked with handling larger numbers of samples.

Tute Genomics Launches MyGene Portal for Genome-guided Medicine
Saturday, September 13, 2014
Selected to showcase healthcare innovation at TEDMED The Hive.

Claritas Genomics Launches Next Generation Sequencing Panel
Saturday, September 13, 2014
ClariFocus Panel to detect genetic causes of nephrotic syndrome in children.

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Tuesday, September 02, 2014
Delivering high quality gDNA from a single cell.

Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels
Tuesday, September 02, 2014
High-performance ClearSeq AML to be followed by series of focused, comprehensive gene panels for cancer research.

Eurofins Genomics Adds NGS to ISO17025 Accredited Testing Portfolio
Saturday, August 16, 2014
ISO17025 accreditation to consistently offer valid results for testing in the fields of veterinary medicine, pharmaceuticals, food and animal feed, commodities and health care.

Bioo Scientific First to Address Small RNA-Seq Bias Concerns
Wednesday, August 13, 2014
Company launches NEXTflex™ Small RNA Sequencing Kit v2.

Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 206
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv